Results 211 to 220 of about 26,531 (270)

Cognitive Sarcopenia: Prevalence and the Risk for Mortality and Healthy Aging in the KORA‐Age Study

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Cognitive sarcopenia, defined by this study as the co‐existence of sarcopenia and cognitive impairment, has been frequently reported in older adults, while we hypothesize that the co‐existence increases the risk for adverse outcomes in the older general population.
Marie‐Theres Huemer   +4 more
wiley   +1 more source

Polygonum cognatum Extract: Multitarget Anti‐inflammatory, Antidiabetic, and Epigenetic Modulation Properties

open access: yesChemistryOpen, Volume 15, Issue 2, February 2026.
Polygonum cognatum extracts exhibit strong antioxidant, anti‐inflammatory, antidiabetic, and antimicrobial activities. This study demonstrates, for the first time, histone deacetylase inhibitory activity, revealing epigenetic modulation potential.
Serhat Karaman   +2 more
wiley   +1 more source

The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: the Hopkins OCD family study

open access: green, 2001
Marco A. Grados   +8 more
openalex   +2 more sources

Feasibility of the Modified Telephone Interview for Cognitive Status (M‐TICS) in the peri‐operative environment

open access: yesAnaesthesia, Volume 81, Issue 2, Page 240-247, February 2026.
Summary Introduction Peri‐operative neurocognitive disorders are common among older adults presenting for surgery and anaesthesia. Cognitive screening is recommended to identify patients at risk for adverse neurocognitive outcomes, though the most appropriate peri‐operative tool remains debated.
Kelly J. Atkins   +6 more
wiley   +1 more source

Glucocorticoid‐Induced Tumor Necrosis Factor Receptor Ligand: Correlation and Therapeutic Potential for Cognitive Impairment in Temporal Lobe Epilepsy

open access: yesClinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT Immune checkpoint regulators can improve neurological functions in Alzheimer's disease. However, it remains blurred whether these regulators may ameliorate temporal lobe epilepsy (TLE) and TLE‐related cognitive impairment. This study analyzed the bulk transcriptomic data of human TLE hippocampi by bioinformatics.
Man Li   +3 more
wiley   +1 more source

Integrating transdiagnostic and holistic approaches in early neurodevelopmental screening

open access: yes
Developmental Medicine &Child Neurology, Volume 68, Issue 3, Page 305-306, March 2026.
Kahoko Yasumitsu‐Lovell
wiley   +1 more source

The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications

open access: yesClinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT Ecopipam is a first‐in‐class dopamine D1 receptor antagonist under investigation for the treatment of Tourette syndrome. This open‐label, fixed‐sequence, three‐cohort study evaluated whether ecopipam induces or inhibits cytochrome P450 (CYP) 1A2, CYP2B6, CYP2C19, CYP2D6, CYP3A4, organic anion‐transporting polypeptide (OATP) 1B1, and p ...
Virginia D. Schmith   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy